Skip to content
OpenCapital
Get started

Innovate VATE Healthcare — Remaining performance obligation amount

Other product segments

Transportation
$510.8M+164%
Industrial
$503.2M+76.3%
Commercial
$264.6M-40.1%
Government
$73.7M-55.9%
Energy
$22.7M+1,319%
Convention
$300K-88.5%

Other financials

Income statement

See full
Revenue$364.8M+33.0%
Gross profit$53.5M+17.6%
Operating income$10.0M+194%
Net income-$16.8M+31.4%
EPS (diluted)-$1.29+31.7%

Balance sheet

See full
Cash & equivalents$134.6M+297%
Total debt$1.4B+11.6%
Total equity-$256.3M-25.5%
Total assets$936.8M+7.9%

Cash flow

See full
Operating cash flow$45.5M+423%
CapEx$200.0K-95.7%
Free cash flow$45.3M+341%

Valuation

See full
Market cap$254.69M+274%

Where this comes from

Reported directly by Innovate in its filing.

Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.

The official record: Innovate’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innovate's healthcare — remaining performance obligation amount.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innovate's healthcare — remaining performance obligation amount?
Innovate (VATE) reported healthcare — remaining performance obligation amount of $210.3M in Q1 2026.
How has Innovate's healthcare — remaining performance obligation amount changed year-over-year?
Innovate's healthcare — remaining performance obligation amount decreased by 14.9% year-over-year, from $247.1M to $210.3M.
What is the long-term trend for Innovate's healthcare — remaining performance obligation amount?
Over 2 years (2023 to 2025), Innovate's healthcare — remaining performance obligation amount has grown at a -25.0% compound annual growth rate (CAGR), from $1.77B to $995.2M.
What does healthcare — remaining performance obligation amount mean?
This metric quantifies the total transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied as of the reporting date for the healthcare segment. It represents the backlog of contracted revenue that the company expects to recognize in future periods. A robust backlog indicates strong commercial momentum and future revenue security.